# Body weight and waist circumference are differentially associated with the response to L-thyroxine treatment in primary hypothyroidism.

- **DOI:** [10.1016/j.jcte.2026.100440](https://doi.org/10.1016/j.jcte.2026.100440)
- **Rating:** Limited (2.6 out of 5)
- **Verdict:** Rare paired CSF measurements generate useful metabolic hypotheses, but unstable modeling in 15 completers prevents reliable mechanistic inference.
- **Framework version:** v5.9
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-10-08
- **Evaluation page:** https://www.nabu.science/paper/10.1016%2Fj.jcte.2026.100440

## Key claims

1. The marked correlations with CSF levels of thyroxine and ORX suggest that hypothalamic mechanisms participate in the regulation of WC and weight during L-thyroxine therapy
   - Support: Tentative
   - Type: Primary finding
   - Basis: hypothalamic mechanism is not identified by correlations from a 15-person observational cohort
   - Location: Abstract, Conclusion
2. Weight gain was positively correlated with CSF ORX levels in the 15 included patients (r = 0.78, p = 0.001).
   - Support: Supported
   - Type: Secondary
   - Basis: large reported correlation with baseline orexin, limited by sample size and exploratory multiple testing
   - Location: Abstract, Results; Results, Change in Body Weight; Figure 4
3. Increased WC correlated negatively with free thyroxine levels, after 6 months of treatment, in both CSF (r = -0.71, p = 0.003) and serum (r = -0.64, p = 0.0097).
   - Support: Supported
   - Type: Secondary
   - Basis: reported bivariate associations are directionally consistent, though the small cohort and multiplicity limit precision
   - Location: Abstract, Results; Results, Change in Waist Circumference; Figure 2

## Strengths

- **Rare paired cerebrospinal-fluid measurements** Thyroid hormones and orexin were measured through lumbar puncture before and during treatment, providing longitudinal human observations that are uncommon in this field.
  - Dimension: contribution
  - Location: Methods, Sampling of Blood and CSF; Discussion, Strengths of the Study
- **Standardized sampling and biochemical procedures** Blood and CSF were collected after fasting at consistent morning times, samples were analyzed in the same run, and the orexin analyst was blinded to clinical data.
  - Dimension: methodological rigour
  - Location: Methods, Sampling of Blood and CSF; Biochemical Procedures
- **Weight and waist treated separately** The analysis distinguishes total weight change from waist-circumference change and reports that they were not correlated, clarifying that the outcomes may reflect different processes.
  - Dimension: contribution
  - Location: Results, Change in Waist Circumference; Change in Body Weight; Discussion, Waist Circumference Dynamics

## Limitations

- **Adjusted waist model changes specification** Statistical Methods specifies a ΔWC model using ΔCSF f-T4, Δweight, and age, whereas Results and Table 2 report visit-two CSF f-T4 and a dose interaction. This unresolved discrepancy affects the central adjusted waist-circumference result.
  - Dimension: methodological rigour
  - Location: Statistical Methods; Results, Change in Waist Circumference; Table 2
- **Regression models exceed available information** With only 15 completers, backward selection produced models containing several predictors and interactions with reported R² values of 0.60–0.82. The described bootstrap validation is not accompanied by optimism-corrected results.
  - Dimension: methodological rigour
  - Location: Methods, Statistical Methods; Results, Table 2
- **Mechanistic claims exceed observational evidence** The paper interprets correlations as evidence that hypothalamic changes play a crucial role and that L-thyroxine may not address them fully. The cohort design and concurrent visit-two measurements cannot establish those mechanisms.
  - Dimension: reporting
  - Location: Abstract, Conclusion; Discussion, Effects of Orexin on Metabolism; Practical Implications

## Reliability checks

Caveats (4 of 4 checks).

- **Results check:** Noted. One reported value does not reconcile, but the key claims do not rest on it.
  - Minor reporting notes (1):
    - Descriptive: "Weight gain was positively correlated with improvement in QoL (r = 0.72, p = 0.003)" (Abstract, Results) vs "Δweight showed significant positive correlations with the changes in the two SF-36 component scores: ΔPCS (r = 0.71, p = 0.003) and ΔMCS (r = 0.70, p = 0.003)" (Results, Change in body weight). Comparing the Abstract with the component-specific Results gives correlations of 0.71 for ΔPCS and 0.70 for ΔMCS rather than 0.72, with both reported p-values remaining 0.003. → Conclusion holds
- **Reporting and transparency:** Noted. The ΔWC regression specification differs between Methods and Results, the displayed thyroid-hormone p-values are not identified as raw or Holm-adjusted, and bootstrap validation is described without reported validation results. These are reporting gaps; their effects on the estimates cannot be determined from the supplied text.
  - Conflict of interest: declared · Ethics approval: declared · Preregistration: not stated · Data availability: not stated · Code availability: not stated
- **Reference integrity:** Noted
  - 54 references in manuscript
  - 54 of 54 checkable references found in an index
  - Citation details diverge for 3 references:
    - #2 Kahn H.S. Tatham L.M. Heath C.W. Jr. Contrasting factors associated with abdominal and peripheral weight gain among adult women Int J Obes Relat Metab Disord 21 10 1997 903 911 9347409 10.1038/sj.ijo.0800490 (DOI resolves to: “Contrasting factors associated with abdominal and peripheral weight gain among adult women” — Kahn, 1997 (International Journal of Obesity). Differs from the DOI’s record on: container, authors) https://doi.org/10.1038/sj.ijo.0800490
    - #40 Liu G. Liang L. Bray G.A. Qi L. Hu F.B. Rood J. Thyroid hormones and changes in body weight and metabolic parameters in response to weight loss diets: the POUNDS LOST trial Int J Obes (Lond) 41 6 2017 878 886 28138133 10.1038/ijo.2017.28 PMC5461198 (DOI resolves to: “Thyroid hormones and changes in body weight and metabolic parameters in response to weight loss diets: the POUNDS LOST trial” — Liu, 2017 (International Journal of Obesity). Differs from the DOI’s record on: container, authors) https://doi.org/10.1038/ijo.2017.28
    - #43 Zijlstra L.E. Jukema J.W. Westendorp R.G.J. Du Puy R.S. Poortvliet R.K.E. Kearney P.M. Levothyroxine Treatment and Cardiovascular Outcomes in older people with Subclinical Hypothyroidism: Pooled Individual results of two Randomised Controlled Trials Front Endocrinol (Lausanne) 12 2021 674841 10.3389/fendo.2021.674841 PMC8173189 34093444 (DOI resolves to: “Levothyroxine Treatment and Cardiovascular Outcomes in Older People With Subclinical Hypothyroidism: Pooled Individual Results of Two Randomised Controlled Trials” — Zijlstra, 2021 (Frontiers in Endocrinology). Differs from the DOI’s record on: container, authors) https://doi.org/10.3389/fendo.2021.674841
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-10-17
